Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom-Reference-Cited by-同舟云学术

Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom

Published:2015-04 Issue:4 Volume:37 Page:804-815
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Cao Xiting,Ejzykowicz Flavia,Ramey Dena R.,Sajjan Shiva,Ambegaonkar Baishali M.,Mavros Panagiotis,Tunceli Kaan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. British Heart Foundation. Coronary Heart Disease Statistics 2012. http://www.bhf.org.uk/publications/view-publication.aspx?ps=1002097.

2. British Heart Foundation. Coronary Heart Disease Statistics. http://www.bhf.org.uk/heart%20health/facts%20and%20statistics.aspx.

3. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias;Emberson;Eur Heart J,2003

4. British Heart Foundation. Modelling the UK burden of Cardiovascular Disease to 2020. http://www.bhf.org.uk/get-involved/campaigning/cardio--vascular-coalition.aspx British Heart Foundation.

5. CHD: Estimating the Impact of Changes in Risk Factors;McPherson,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy;Cardiology and Therapy;2021-09-29

2. Electronic Health Record Databases;Pharmacoepidemiology;2019-10-18